Valeant Pharmaceuticals Intl Inc: Pearson Out, Ackman In, Stock UpMark Melin
With trading halted this morning for news on Valeant Pharmaceuticals near 9AM EST, that news came in strong this morning as the embattled firm announced that CEO J. Michael Pearson was stepping down, its best known investor, William Ackman of Pershing Square Management, was being installed on the board of directors, the firm acknowledged “material weaknesses” in its financial . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email firstname.lastname@example.org and we will get back to you as quick as humanly possible